Background: Propofol emulsion in medium and long-chain triglycerides (MCT/LCT) has been reported to cause less injection pain than other propofol solutions in adult studies. The aim of this study was to compare the injection pain of two different propofol emulsions using two different pain scales on the pediatric population. Materials and Methods: 100 children scheduled for general anesthesia were divided into two groups. Patients were randomly assigned to receive propofol LCT or propofol MCT/LCT. Assessment and evaluation of the Ontario Children's Hospital Pain Scale (mCHEOPS) and the Wong-Baker Faces Scale (WBFS) were performed at the start of the injection until the patients lose consciousness.
Introduction
Propofol is a popular anesthetic agent in pediatric practice, with the benefits of smooth induction characteristics, an antiemetic effect, rapid recovery, and pleasant waking up. However, during a propofol injection, pain due to the long-chain triglyceride (LCT) emulsion is experienced Despite various strategies to reduce propofol injection pain, this still represents a clinical problem in adults and children, with A large meta-analysis suggested that lidocaine is most effective in preventing pain when given before propofol and by applying a tourniquet Although a were adults. In practice, many children, particularly in the younger age group, object to a tourniquet being applied for this length of time. A circumferential squeeze with warm hands may be somewhat less threatening to the child, but it may not be reliable as a tourniquet. The most popular method to prevent painful injections, preferred by most anesthesiologists, is mixing lidocaine with propofol immediately before injection. Recently, a medium-chain triglyceride/long-chain triglyceride (MCT/LCT) emulsion has been advocated to reduce injection pain compared with propofol LCT in adults and teenagers.
We compared the injection pain of two propofol emulsions to show their effectiveness on two pain scales in children of different age groups.
Materials and Methods
Ethical approval for this study was provided by the Ethics years, in American Society Anesthesiologists (ASA) class I, undergoing elective general anesthesia without any contraindication to propofol anesthesia were included in the A-13 study. Patients with a known allergic history to medication being used were excluded.
The patients were fasted for 6 h, but clear liquids allowed
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® cream was applied to an antecubital vein for intravenous cannula was inserted and an infusion line attached. Electrocardiogram, systolic, diastolic, mean blood pressure, heart rate, and peripheral oxygen saturation (SpO ) were monitored in the operating room. In the adjoining room, labeled propofol solutions were prepared by a blinded anesthetist. The patients were randomized by preprepared sealed envelopes to receive one of the two
The same two blinded anesthetists assessed injection pain using two pain scales, the Ontario Children's Hospital Pain Scale (mCHEOPS) and the Wong-Baker Face Scale for each patient group (children rated their pain severity on a VAS from mention the scores and its corresponding value, for was made until the patient lost consciousness. Following the induction of anesthesia, the study was terminated and anesthesia was continued as necessary in relation to the planned surgical A power analysis was performed using the G * packet programme (Faul, Universität Kiel, Germany). The Chicago, IL) was used for statistical analysis. A Student's t-test was used to compare parametric data, including demographic characteristics. Chi-square test was used for frequency comparisons. For statistical significance, a p considered as significant.
Results
The demographic data of patients (age, sex, weight, and ASA physical status), propofol amounts, surgical durations, and recovery periods revealed no significant differences between groups (P There was no significant difference between age distributions (P When the Propofol LCT and Propofol MCT/LCT groups were compared in terms of pain scales, the LCT group had significantly less pain on both scales (Chi-square test: P P to WBFS). On both the scales, the injection pain score was 4 or higher. The mCHEOPS scale revealed the incidence of P (P When patients were evaluated by age distribution, according to the mCHEOPS scale, children aged 3-6 had a pain LCT [ Table 3 ]. The number of male patients in each group was greater. Different responses to propofol injection pain were recorded in each gender.
Discussion
Propofol is currently the preferred intravenous general anesthetic drug with a smooth induction, pleasant sleep, rapid recovery, and low incidence of nausea and vomiting.-Despite these positive properties, it also has adverse effects such as injection pain, which may discomfort in the induction of anesthesia. The incidence of pain on injection of propofol in children has been
In order to improve this, a number The mechanism of pain on injection of propofol is thought to be multifactorial but its exact causation is not clear. The most commonly identified mechanism is release of bradykinin as a result of the activation of the plasma kinin-kallikrein system by propofol. Among the mechanisms to relieve injection pain of propofol, lipid carrier and concentration of propofol emulsion in the aqueous phase were reported to have an important role. The concentration of free propofol in the aqueous phase of propofol MCT/LCT is approximately of free propofol in the aqueous phase of the emulsion have been reported to be associated with more pain on injection.
Injection site and speed, aqueous phase free propofol concentration, the buffering effect of blood, temperature of propofol, injector material, and some addition of local anesthetics or opioids have been investigated. However, none of these factors explained injection pain, and unfortunately injection pain could not be prevented. In order to decrease propofol pain, lidocaine pretreatment (either before or mixed with propofol) is mostly preferred. Again, a tourniquet can be used before lidocaine pretreatment to decrease pain quite effectively. Jalota et al. conducted a meta-analysis and suggested using a routine low-dose opioid before the propofol injection. Antecubital veins should be preferred instead of the dorsum of hands. In addition, lidocaine should be administered before an injection of propofol MCT/LCT emulsions with/without venous occlusions. Many adult studies show that the injection pain severity of intravenous propofol MCT/LCT is less than propofol LCT emulsion.
However, the age distribution intervals in pediatric studies are wide. The study by Nyman et al. had
Varghese et al. Another common feature of all these studies was that only one scale was evaluated on all of the selected patient populations. However, a 3-year-old child is not the same as a and it should rather be selected according to age. The varying results reported in children may be a result from different methodologies used to decrease injection pain. In this study, we evaluated injection pain with two distinct scales. We could not find any significant difference in the groups using both the scales. Although Nyman et al. suggested that boys and girls have different pain reactions to propofol injections, we found similar reactions to propofol injections among boys and girls.
Although it has been shown that lidocaine added to propofol is highly effective, we did not use lidocaine on patients in this study. We decided not to use lidocaine with propofol because the results of this study would be affected negatively and it would be impossible to obtain objective results.
In conclusion, propofol MCT/LCT caused more injection pain than propofol LCT. However, to clarify these clinically observed controversial results, there is a need for further studies on children with more standardized distributions of sex and age. We suggest the use of mCHEOPS scale for children in future studies as its implementation is easier than that of other scales.
